News
Public · Published
Broker's Call: Dixon Technologies (Buy)
Keynote Capitals maintained a Buy rating on Dixon Technologies, citing a target of ₹14,417 against a stated current market price of ₹12,270.1. For Q2 FY27, Dixon reported strong year-on-year revenue growth, while gross and EBITDA margins—which show how much revenue remains after costs—contracted by 202 and 104 basis points, respectively.
Published:
Updated:
What happened
Keynote Capitals maintained a Buy rating on Dixon Technologies, citing a target of ₹14,417 against a stated current market price of ₹12,270.1. For Q2 FY27, Dixon reported strong year-on-year revenue growth, while gross and EBITDA margins—which show how much revenue remains after costs—contracted by 202 and 104 basis points, respectively.
Confirmed
Global impact / market context
The reported margin declines show that strong sales growth has not fully translated into profit per sale. The article attributes pressure to the end of Mobile PLI 1.0 incentives and higher memory prices; if those costs persist, they could limit how much revenue growth improves earnings.
Analyst inference
The article describes a policy transition: the earlier mobile incentive ended in March 2026, and a new manufacturing scheme was notified in August 2026 with ₹62,500 crore over five years. Its support for manufacturers could shape future investment, but the article does not specify Dixon’s allocation.
Confirmed
What to watch
- Whether the new manufacturing scheme results in support for Dixon is important, since the article gives the scheme’s total funding but does not identify a company allocation. Analyst inference
- Track whether Dixon’s gross and EBITDA margins recover as mobile volumes grow, because persistent memory costs or reduced incentives could keep profit growth behind revenue growth. Analyst inference
- Dixon is evaluating advanced electronics work and exploring Indian partnerships; concrete commitments in silicon photonics, optical transceivers, or semiconductor packaging would clarify its investment plans. Confirmed
Evidence
- Original source link unavailable